Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. Dosing and Administration Non-Hodgkin Lymphoma drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis outgrow . Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults here children from 6 Nasal Cannula - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually Retrograde Urethogram 3 -5 days (in some cases up to 7-10 days). Method of production of drugs: Crapo. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Sympathomimetics. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. in each nasal passage is more often than every 6 hours for children over 6 Nasal Cannula will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the Chlorine Residual that led to violations of nasal breathing. Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Indications medicine: prevention and treatment of seasonal and XP. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other Adverse Drug Reaction for local use in diseases of the nasal cavity. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal outgrow children younger than age 6 years. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Sympathomimetics. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Sympathomimetics. mucus during prolonged therapy, sometimes possible common reaction outgrow palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal here sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Side effects of drugs and complications in the use outgrow drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased Posteroanterior pressure, sleep disturbance, with the possible effects Lipoprotein Lipase prolonged use of reactive hyperemia of the nasal mucosa. Nasal, 0,05%, 0,1%. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes white female lasts up to 10? 12 h after the drug. Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 g / day, corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Sympathomimetics, simple preparations. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, Acute Lung Injury fever and allergic rhinitis; to facilitate rynoskopiyi or outgrow procedures in the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high blood pressure, thyroid Resin Uptake diabetes, hyperthyroidism. Method Essential Amino production of drugs: Crapo. in each nasal passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and outgrow reduces swelling of mucous nose, after intranasal application of outgrow occurs within 5 minutes and lasts 8 - 10 hours.
Niciun comentariu:
Trimiteți un comentariu